Shihe Hou

Learn More
PURPOSE nab-paclitaxel demonstrates improved clinical efficacy compared with conventional Cremophor EL (CrEL)-paclitaxel in multiple tumor types. This study explored the distinctions in drug distribution between nab-paclitaxel and CrEL-paclitaxel and the underlying mechanisms. METHODS Uptake and transcytosis of paclitaxel were analyzed by vascular(More)
  • 1